Your browser is no longer supported. Please, upgrade your browser.
ABT Abbott Laboratories daily Stock Chart
Abbott Laboratories
IndexS&P 500 P/E61.29 EPS (ttm)0.67 Insider Own0.30% Shs Outstand1.72B Perf Week-0.65%
Market Cap70.00B Forward P/E16.84 EPS next Y2.42 Insider Trans25.26% Shs Float1.72B Perf Month5.38%
Income993.00M PEG6.24 EPS next Q0.65 Inst Own74.30% Short Float4.45% Perf Quarter1.07%
Sales20.71B P/S3.38 EPS this Y53.50% Inst Trans0.00% Short Ratio8.38 Perf Half Y-1.23%
Book/sh14.07 P/B2.90 EPS next Y9.80% ROA3.40% Target Price46.62 Perf Year3.37%
Cash/sh2.62 P/C15.53 EPS next 5Y9.82% ROE6.60% 52W Range35.11 - 45.21 Perf YTD6.80%
Dividend1.06 P/FCF234.90 EPS past 5Y-10.30% ROI7.70% 52W High-10.22% Beta1.41
Dividend %2.60% Quick Ratio1.20 Sales past 5Y-10.30% Gross Margin56.90% 52W Low15.61% ATR0.70
Employees74000 Current Ratio1.60 Sales Q/Q3.00% Oper. Margin14.70% RSI (14)60.43 Volatility1.57% 1.68%
OptionableYes Debt/Eq0.38 EPS Q/Q-161.10% Profit Margin6.60% Rel Volume0.25 Prev Close40.76
ShortableYes LT Debt/Eq0.29 EarningsJan 25 BMO Payout112.60% Avg Volume9.13M Price40.59
Recom1.90 SMA203.21% SMA503.94% SMA2000.91% Volume123,456 Change-0.42%
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Jan-19-17 07:00AM  This Could Be The Biggest Winner Of 2017s Biotech Boom
Jan-18-17 10:54AM  ACCURATE Study Confirms Superiority Of Abbott Laboratories (ABT) Dorsal Root Ganglion (DRG) Stimulation at Insider Monkey
08:00AM  Abbott Announces European Launch of the Proclaim DRG Neurostimulation System for the Management of Chronic Neuropathic Pain PR Newswire
Jan-17-17 08:00AM  New Data Confirms Abbott's Dorsal Root Ganglion Stimulation Offers Greater Treatment Success over Traditional Spinal Cord Stimulation PR Newswire
Jan-16-17 04:08PM  Adient Stock: Still Undervalued After Johnson Controls Spinoff
11:30AM  5 Trade Ideas for Tuesday: Abbott Labs, Applied Materials, Citrix, Graco and Lowe's
Jan-14-17 12:01AM  [$$] Credit Suisse Likes Expedia's Mash-Up of Brands at
Jan-13-17 09:07AM  Inside Johnson & Johnsons Latest Dividend Payment
07:36AM  Understanding Johnson & Johnsons Medical Device Business Lawsuit Troubles
Jan-12-17 05:43PM  Short seller on Time Warner-AT&T
04:00PM  Abbott Announces U.S. Launch and First Commercial Use of the New EnSite Precision Cardiac Mapping System PR Newswire
09:08AM  Johnson & Johnsons Diabetes Launch to Accelerate the Medical Device Business
Jan-11-17 02:19PM  Alinity ci-series Of Diagnostic Systems From Abbott Laboratories (ABT) Obtains CE Mark at Insider Monkey
12:56PM  Analyst Reports for Facebook, Bank of America & ConocoPhillips
Jan-10-17 07:07PM  US warns of unusual cybersecurity flaw in heart devices
02:26PM  Abbott Labs Stock Trades Ex-Dividend Wednesday at Investopedia
08:15AM  Blog Coverage ReWalk Announced 2017 Outlook; to Reduce Operating Expenses by up to 30% Accesswire
07:00AM  Abbott Announces CE Mark for its Alinity ci-series Diagnostic Systems PR Newswire
07:00AM  Abbott Announces CE Mark for its "Alinity s" Blood and Plasma Screening System PR Newswire
Jan-09-17 06:34PM  St. Jude releases cyber updates for heart devices after U.S. probe Reuters
06:28PM  The Best DRIP Stocks: 15 No-Fee Dividend Aristocrats
05:27PM  [$$] Abbott's St. Jude Patches Device Software After Regulators Confirm Weaknesses at The Wall Street Journal
04:04PM  Muddy Waters' Carson Block: Announced Tech Fixes Do Not Appear To Address Many Of The Larger Problems For Abbott-St. Jude
12:36PM  St. Jude release cyber updates for heart devices after government probe Reuters
12:25PM  Abbott releases cyber updates after government probe
12:00PM  Abbott releases cyber updates for St. Jude devices after gov't probe Reuters
06:55AM  Will Johnson & Johnson Shock Investors with a Spin-off in 2017? at Motley Fool
Jan-08-17 08:35AM  Parkinson's Therapy Gets Fresh Look From Device Makers at The Wall Street Journal
Jan-05-17 05:42PM  Top 7 Dividend Health Care Stocks
04:25PM  ABBOTT LABORATORIES Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disp
10:33AM  Abbott Laboratories Value Analysis (NYSE:ABT) : January 5, 2017
07:35AM  How Do Wall Street Analysts View Becton Dickinson?
Jan-04-17 04:30PM  Abbott Completes the Acquisition of St. Jude Medical PR Newswire
10:35AM  A Look at Becton Dickinsons Recent Stock Performance
08:10AM  Abbott Laboratories breached its 50 day moving average in a Bullish Manner : ABT-US : January 4, 2017
07:35AM  BDs Latest Dividend Payment and Capital Allocation Strategy
Jan-03-17 06:35PM  IDEXX Laboratories Set to Join the S&P 500; Chemours to Join S&P MidCap 400; Shake Shack to Join S&P SmallCap 600 PR Newswire
12:59PM  Husband of Top Trump Advisor Conway Said to be a Finalist For U.S. Solicitor General
12:00PM  Abbott Labs: Diagnosing Growth in 2017
10:05AM  Abbott Closes St. Jude Medical Deal Wednesday
08:25AM  5 Merrill Lynch Stocks to Buy That Are 2017 Dividend Aristocrats
08:15AM  Blog Coverage Abbott and St. Jude Medical Merger Gets OK from US and China's Anti-Trust Regulators Accesswire
07:36AM  BDs Medical Segment Performance and Growth Strategy
Jan-02-17 10:37AM  BD Lifesciencess Product Pipeline Could Boost Its Fiscal 2017 Growth
09:07AM  BD Lifesciencess Performance and Core Focus Areas
07:40AM  Abbott Labs to Close St. Jude Acquisition Later this Week
07:36AM  What Was St. Jude Medicals Latest Dividend Payment?
Jan-01-17 05:48PM  Bargain Hunting: The 10 Worst-Performing Dividend Achievers of 2016
03:40PM  Here's Your Last Chance to Sell Shake Shack, 4 More 'Toxic Stocks' in 2016
Dec-31-16 09:10AM  Abbott Sets Closing Date for St. Jude Medical Deal at Investopedia
Dec-30-16 12:30PM  Abbott Acquisition of St. Jude Medical Set to Close on January 4, 2017 PR Newswire
09:24AM  FTC Approved Abbotts Acquisition of St. Jude Medical
08:40AM  AbbVie's Humira and Imbruvica Drive Performance in 2016
Dec-29-16 05:38PM  Abbott to Sell 2 Medical Device Businesses for St. Jude Buyout
12:48PM  Farr: My top 10 stocks for 2017 at CNBC
11:13AM  Dividend Stock Picks Could Look Even Better in Coming Weeks
08:51AM  [$$] Alere Files Appeal With CMS Judge Over Medicare Billing Decision at The Wall Street Journal
08:30AM  Abbott's St. Jude Deal Aligns With Shift To Value-Based Care at Forbes
Dec-28-16 12:57PM  Abbott Labs to Buy St. Jude Medical for $25 Billion
08:59AM  The Market In 5 Minutes: Redbook Retail Sales Higher Across The Board
07:00AM  FTC Allows Abbott to Spin Off Units, Buy St. Jude Medical
Dec-27-16 04:31PM  Top Research Reports for 27th December, 2016
02:30PM  Abbott gets U.S. antitrust approval to buy St. Jude Medical Reuters
11:02AM  Cluster of Insider Buying at Inovalon Holdings Inc. (INOV) after Slashing Guidance, Plus Other Noteworthy Pre-Holiday Insider Transactions at Insider Monkey
08:30AM  Top 10 Dividend Stocks You Need to Buy Now to Prepare for 2017
06:00AM  Most Important Mergers and Acquisitions of 2016 at Investopedia
Dec-24-16 02:35PM  Top Insider Buys of the Week
Dec-23-16 11:45AM  The 10 Best Dividend Aristocrats for 2017 and Beyond
10:53AM  11 tax-loss stocks to pick up before the end of the year at MarketWatch
Dec-22-16 11:34AM  Exclusive: U.S. regulator poised to approve Abbott purchase of St Jude - sources Reuters
Dec-21-16 03:38PM  Insiders Buy Abbott Laboratories Shares After Merger Deal Sours
09:00AM  Abbott Hosts Conference Call for Fourth-Quarter Earnings PR Newswire
Dec-19-16 02:57PM  Dividend Growth Stocks For Further Research at Insider Monkey
09:00AM  Abbott to Present at J.P. Morgan Healthcare Conference PR Newswire
Dec-16-16 05:01PM  ABBOTT LABORATORIES Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
Dec-15-16 09:14AM  The Worst Dividend Aristocrats of 2016 at Motley Fool
Dec-14-16 05:25PM  The 10 Best Dividend Achievers
Dec-13-16 07:00AM  Top 10 Holdings of Our Ultimate Stock-Pickers' Index at Morningstar
Dec-12-16 09:37AM  Aleres Response to Abbott Laboratoriess Lawsuit to Terminate the Merger
08:06AM  How Analysts View Abbott Laboratoriess Deal Termination Lawsuit
Dec-10-16 12:01AM  [$$] J&J Deserves Some Healthy Respect at
12:01AM  [$$] A Top Dividend Fund's Newest Favorites at
Dec-09-16 05:35PM  A Deep Dive into the Developments at Alere
04:51PM  ABBOTT LABORATORIES Files SEC form 8-K, Change in Directors or Principal Officers
04:05PM  Why Abbott Laboratories Seeks to Terminate the Alere Acquisition
04:04PM  Abbott Laboratories Announces Quarterly Dividend
02:17PM  A Brief Recap of the AbbottAlere Deal Developments
10:25AM  Abbott Raising Quarterly Dividend for 45th Straight Year PR Newswire
Dec-08-16 09:00AM  Mylan (MYL) Stock Falls on Restructuring Plans, Layoffs
Dec-07-16 05:00PM  Abbott sues Waltham's Alere to end $5.8 billion buyout at
04:43PM  A broad rally drives Dow, S&P 500 indexes to record highs AP
02:05PM  Abbott wants out of $5.8 billion Alere deal at
01:31PM  [$$] Abbott Seeks to Terminate Alere Deal at The Wall Street Journal
12:59PM  Alere Issues Statement Regarding Abbott Lawsuit PR Newswire
11:51AM  Abbott seeks to end buyout deal for Alere
11:51AM  Abbott Looks to Kill Alere Deal
11:49AM  Abbott Seeks To Terminate Alere Acquisition: 'Not The Company We Agreed To Buy'
11:27AM  Abbott seeks to abort planned acquisition of Alere
11:19AM  Abbott seeks to terminate Alere acquisition
11:17AM  Abbott Files Suit to Terminate $5.8 Billion Alere Purchase at Bloomberg
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. In addition, it develops cardiovascular medical devices. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company has strategic alliance with Fonterra. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blaser Brian JExecutive Vice PresidentDec 20Buy38.4515,580599,120145,062Dec 21 02:19 PM
Ford Robert BExecutive Vice PresidentDec 14Buy39.0912,775499,34569,542Dec 16 05:07 PM
CAPEK JOHN MExecutive Vice PresidentNov 16Option Exercise24.3822,000536,386274,524Nov 18 05:02 PM
WHITE MILES DChairman and CEONov 10Buy40.6758,2632,369,4483,111,967Nov 14 10:04 AM
WHITE MILES DChairman and CEONov 10Buy40.5389,5783,630,2943,004,943Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.6548,7611,982,0793,053,704Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.5451,8922,103,4552,793,909Nov 14 10:02 AM
WHITE MILES DChairman and CEONov 10Buy40.45121,4564,912,7412,915,365Nov 14 10:02 AM
Blount Sally E.DirectorNov 01Buy39.245,100200,12420,143Nov 02 05:12 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale41.7181533,99458,976Sep 28 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 29Option Exercise25.2556,0001,413,782438,682Jul 29 05:04 PM
Fussell Stephen RExecutive Vice PresidentJul 28Option Exercise25.2541,5001,047,713196,467Jul 29 05:03 PM
Fussell Stephen RExecutive Vice PresidentJul 28Sale45.0041,5001,867,640154,967Jul 29 05:03 PM
Warmuth Michael JExecutive Vice PresidentJul 26Option Exercise25.2526,800676,59581,811Jul 27 04:43 PM
Warmuth Michael JExecutive Vice PresidentJul 26Sale43.4926,8001,165,45755,011Jul 27 04:43 PM
WHITE MILES DChairman and CEOJul 25Option Exercise25.25550,00013,885,3552,010,517Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Option Exercise25.2526,800676,595111,819Jul 27 04:44 PM
WHITE MILES DChairman and CEOJul 25Buy43.3417,933777,1622,742,017Jul 27 04:31 PM
WHITE MILES DChairman and CEOJul 25Buy43.26176,8047,648,8232,724,084Jul 27 04:30 PM
WHITE MILES DChairman and CEOJul 25Buy43.19181,2637,828,6282,434,327Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.34112,9534,895,2172,547,280Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.18242,54710,472,9392,253,064Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Sale43.0826,8001,154,54485,019Jul 27 04:44 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Option Exercise20.753,40070,54591,857Jun 30 05:58 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Sale37.143,400126,27688,457Jun 30 05:58 PM
Watkin JaredSenior Vice PresidentJun 15Sale37.6355220,77046,562Jun 17 05:05 PM
YOOR BRIAN BSenior Vice President and CFOJun 01Sale39.4956522,31249,617Jun 03 05:10 PM
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM
Contreras JaimeSenior Vice PresidentMar 31Sale41.7846219,3042,426Apr 01 05:01 PM
Ford Robert BExecutive Vice PresidentFeb 29Sale39.281,70667,02060,789Mar 02 07:32 PM
NATH DEEPAK S.Senior Vice PresidentFeb 29Sale39.2779331,14247,571Mar 02 07:30 PM
Fussell Stephen RExecutive Vice PresidentFeb 29Sale39.261,40255,044154,967Mar 02 07:28 PM
Contreras JaimeSenior Vice PresidentFeb 29Sale38.9410,617413,40947,667Mar 02 07:28 PM
Blaser Brian JExecutive Vice PresidentFeb 29Sale39.291,54360,626129,482Mar 02 07:12 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 29Sale39.291,54360,61888,457Mar 02 07:11 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 29Sale39.283,086121,221354,517Mar 02 07:10 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentFeb 29Sale39.2688134,58961,792Mar 02 07:02 PM
YOOR BRIAN BSenior Vice President and CFOFeb 29Sale39.1286533,84351,385Mar 02 07:01 PM
Mason Heather LExecutive Vice PresidentFeb 29Sale39.273,032119,05565,102Mar 02 06:49 PM
Funck Robert EVice President, ControllerFeb 29Sale39.301,33352,39385,019Mar 02 06:07 PM
Warmuth Michael JExecutive Vice PresidentFeb 29Sale38.849,399365,09355,011Mar 02 05:14 PM
Pavee Jean-YvesSenior Vice PresidentFeb 29Sale39.241,66565,32636,149Mar 02 05:09 PM
NATH DEEPAK S.Senior Vice PresidentFeb 22Sale39.0931912,47150,404Feb 23 05:44 PM
Watkin JaredSenior Vice PresidentFeb 22Sale39.0955421,65848,535Feb 23 05:38 PM
NATH DEEPAK S.Senior Vice PresidentFeb 16Sale37.131716,34934,941Feb 17 05:57 PM